These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 27576516)

  • 1. Cyclosporine Reduces Sclerosis in Morphea: A Retrospective Study in 12 Patients and a Literature Review.
    Bali G; Frühauf J; Wutte N; Aberer E
    Dermatology; 2016; 232(4):503-10. PubMed ID: 27576516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diagnostic and therapeutic problems of scleroderma].
    Pogorzelska-Antkowiak A; Antkowiak R
    Wiad Lek; 2006; 59(5-6):392-5. PubMed ID: 17017489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind, placebo-controlled study of oral calcitriol for the treatment of localized and systemic scleroderma.
    Hulshof MM; Bouwes Bavinck JN; Bergman W; Masclee AA; Heickendorff L; Breedveld FC; Dijkmans BA
    J Am Acad Dermatol; 2000 Dec; 43(6):1017-23. PubMed ID: 11100017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localized scleroderma: a clinical study at a single center in Korea.
    Noh JW; Kim J; Kim JW
    Int J Rheum Dis; 2013 Aug; 16(4):437-41. PubMed ID: 23992265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinoic acid for treatment of systemic sclerosis and morphea: A literature review.
    Thomas RM; Worswick S; Aleshin M
    Dermatol Ther; 2017 Mar; 30(2):. PubMed ID: 28032675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclosporine induced biochemical remission in childhood autoimmune hepatitis.
    Franulović OZ; Rajacić N; Lesar T; Kuna AT; Morić BV
    Coll Antropol; 2012 Sep; 36(3):973-9. PubMed ID: 23213960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial.
    Choudhry S; Bagga A; Hari P; Sharma S; Kalaivani M; Dinda A
    Am J Kidney Dis; 2009 May; 53(5):760-9. PubMed ID: 19268410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low effectiveness of methotrexate in the management of localised scleroderma (morphea) based on an ultrasound activity score.
    Vera-Kellet C; Meza-Romero R; Moll-Manzur C; Ramírez-Cornejo C; Wortsman X
    Eur J Dermatol; 2021 Dec; 31(6):813-821. PubMed ID: 35107072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localized scleroderma: a series of 52 patients.
    Toledano C; Rabhi S; Kettaneh A; Fabre B; Fardet L; Tiev KP; Cabane J
    Eur J Intern Med; 2009 May; 20(3):331-6. PubMed ID: 19393504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of topical tacrolimus 0.1% in active plaque morphea: randomized, double-blind, emollient-controlled pilot study.
    Kroft EB; Groeneveld TJ; Seyger MM; de Jong EM
    Am J Clin Dermatol; 2009; 10(3):181-7. PubMed ID: 19354332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term treatment of focal segmental glomerulosclerosis in children with cyclosporine given as a single daily dose.
    Chishti AS; Sorof JM; Brewer ED; Kale AS
    Am J Kidney Dis; 2001 Oct; 38(4):754-60. PubMed ID: 11576878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid response to cyclosporine and maintenance with methotrexate in linear scleroderma in a young girl.
    Pérez Crespo M; Betlloch Mas I; Mataix Díaz J; Lucas Costa A; Ballester Nortes I
    Pediatr Dermatol; 2009; 26(1):118-20. PubMed ID: 19250434
    [No Abstract]   [Full Text] [Related]  

  • 13. Linear morphea: a case series with long-term follow-up of young, methotrexate-treated patients.
    Koch SB; Cerci FB; Jorizzo JL; Krowchuk DP
    J Dermatolog Treat; 2013 Dec; 24(6):435-8. PubMed ID: 23758214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Remission rates and risk factors for relapse in pediatric morphea: a multicenter retrospective study of Pediatric Rheumatology Academy (PeRA)-Research Group (RG).
    Bağlan E; Kızıldağ Z; Çağlayan Ş; Çakmak F; Yener GO; Özdel S; Öztürk K; Makay B; Çakan M; Ayaz NA; Sözeri B; Ünsal ŞE; Bülbül M
    Clin Rheumatol; 2023 Oct; 42(10):2855-2860. PubMed ID: 37378874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory arthritis in pediatric patients with morphea.
    Kashem SW; Correll CK; Vehe RK; Hobday PM; Binstadt BA; Maguiness SM
    J Am Acad Dermatol; 2018 Jul; 79(1):47-51.e2. PubMed ID: 29535035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early- and late-stage morphea subtypes with deep tissue involvement is treatable with Abatacept (Orencia).
    Adeeb F; Anjum S; Hodnett P; Kashif A; Brady M; Morrissey S; Devlin J; Fraser AD
    Semin Arthritis Rheum; 2017 Jun; 46(6):775-781. PubMed ID: 27773434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Juvenile case of multiple morphea profunda resulting in joint contracture that was successfully treated with cyclosporin A: A case report and review of the published works.
    Ogawa T; Okiyama N; Takamuki R; Inoue S; Saito A; Nakamura Y; Ishitsuka Y; Watanabe R; Fujisawa Y; Fujimoto M
    J Dermatol; 2019 Apr; 46(4):354-357. PubMed ID: 30701571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A boy with a tight skin: Borrelia-associated early-onset morphea.
    Verberkt RM; Janssen M; Wesseling J
    Clin Exp Rheumatol; 2014; 32(1):121-2. PubMed ID: 24093617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psoralen UVA therapy for linear and generalized morphea.
    Morison WL
    J Am Acad Dermatol; 1997 Oct; 37(4):657-9. PubMed ID: 9344214
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of morphea with hydroxychloroquine: A retrospective review of 84 patients at Mayo Clinic, 1996-2013.
    Kumar AB; Blixt EK; Drage LA; El-Azhary RA; Wetter DA
    J Am Acad Dermatol; 2019 Jun; 80(6):1658-1663. PubMed ID: 30703458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.